Otsuka Holdings
4578.T
#741
Rank
NZ$54.34 B
Marketcap
NZ$102.89
Share price
1.03%
Change (1 day)
4.72%
Change (1 year)
Otsuka Pharmaceutical Co., Ltd. is a Japanese pharmaceutical company involved in the R&D of drugs and healing methods for respiratory diseases, eye diseases, cardiovascular diseases, neurological and mental diseases as well as Parkinson's, tuberculosis and cancer.

Earnings for Otsuka Holdings (4578.T)

Earnings in 2023: NZ$1.81 Billion

According to Otsuka Holdings 's latest financial reports the company's current earnings are NZ$14.47 Billion. In 2023 the company made an earning of NZ$1.81 Billion a decrease over its 2022 earnings that were of NZ$2.29 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Otsuka Holdings from 2010 to 2023

Annual earnings

Year Earnings Change
2023NZ$1.81 B-20.93%
2022NZ$2.29 B-12.7%
2021NZ$2.63 B-19.92%
2020NZ$3.28 B13.9%
2019NZ$2.88 B52.07%
2018NZ$1.89 B11.22%
2017NZ$1.70 B-36.03%
2016NZ$2.66 B31.15%
2015NZ$2.03 B
2013NZ$4.21 B33.52%
2012NZ$3.16 B-4.65%
2011NZ$3.31 B45.53%
2010NZ$2.27 B